A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
This study is currently recruiting participants.
Verified April 2013 by Threshold Pharmaceuticals
Study NCT01440088
Information provided by Threshold Pharmaceuticals
First Received on September 20, 2011.
Last Updated on April 3, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
